NCT06364358

Brief Summary

The goal of this pilot clinical trial is to evaluate a culturally tailored computerized education program in hospitalized African-American patients with advanced chronic kidney disease (CKD). The main question it aims to answer are: does computerized adaptive education (CAE) increase patients' knowledge about CKD self-care and renal replacement therapy (RRT) options compared to usual care (UC) and will CAE will be increase patients' intent to participate in CKD self-care and RRT preparation compared to UC

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
May 2023Sep 2026

First Submitted

Initial submission to the registry

May 18, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

May 31, 2023

Completed
11 months until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Expected
Last Updated

January 8, 2025

Status Verified

August 1, 2024

Enrollment Period

2 years

First QC Date

May 18, 2023

Last Update Submit

January 7, 2025

Conditions

Keywords

African AmericanHospitalizedPatient education

Outcome Measures

Primary Outcomes (3)

  • Change in CKD Knowledge baseline to post patient education intervention

    The Kidney Disease Knowledge Questionnaire (KIKS) is a validated instrument that assesses CKD knowledge. Scores range from 0 (no knowledge)-28 (full knowledge). Change =Post intervention-Baseline scores

    Baseline and 1 day post-intervention

  • Change in Knowledge about end stage kidney disease (ESKD) treatments from baseline to 1 day post patient education intervention

    The Kidney Failure Treatment Knowledge is an investigator developed tool that assesses knowledge of 6 ESKD treatment options using a Likert scale (0=no knowledge and 4=a great deal of knowledge). Possible scores range from 0-24

    Baseline and 1 day post-intervention

  • Change in ESKD Treatment Preferences from baseline to 1 day post-intervention

    The Kidney Failure Treatment Preferences Survey is an investigator developed tool that assess change in certainty of preference for each of six ESKD treatments. Scores range -12 to 12 with each question scored as -2 extremely unlikely to choose a modality to +2 extremely likely to choose a modality with a change from 0 (in any direction) as an increase in certainty.

    Baseline and 1 day post-intervention

Secondary Outcomes (3)

  • Change in Patient Activation Measure from Baseline to 30 days Post-intervention

    Baseline, 1 day post-intervention, and 30 day follow-up

  • Increase in Health Intent baseline to post intervention (at 1 day and 30 day follow-up)

    Baseline, 1 day post-intervention and 30 day follow-up

  • CKD Self-Management from baseline to 30 day post-intervention

    Baseline and 30 day follow-up

Study Arms (2)

Usual Care

ACTIVE COMPARATOR

The research assistant (RA) will use tablet to give participants baseline General Health Knowledge and Intent survey and leave printed patient education materials about general health maintenance. In the initial consent, pre-intervention survey and education materials, investigators will not provide CKD specific knowledge or inform participants about their CKD.

Behavioral: Usual Hospital Care

Computerized Patient Education

EXPERIMENTAL

The RA will assist participants in starting the computer program and encourage review of the advanced CKD education module. The computer-adaptive education module will alter the content of education topics based on some preliminary participant information.

Behavioral: Computerized CKD Education

Interventions

The intervention is a culturally tailored computer-based adaptive program (developed during this intervention) to educate patients about kidney disease and renal replacement therapy options.

Computerized Patient Education

Computer based patient education materials about general healthy lifestyle that will include information about the importance of a healthy diet, physical activity and medical adherence

Usual Care

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • African-American inpatients
  • Ages 18-70
  • estimated glomerular filtration rate (eGFR)\<45
  • Enrolled in the Hospitalist Project

You may not qualify if:

  • Does not self-identify as African American
  • Not able to consent
  • Unable to speak English
  • eGFR \<45 due to acute kidney injury
  • In Intensive Care Unit
  • has had a transplant
  • currently on dialysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Chicago Medical Center

Chicago, Illinois, 60637, United States

RECRUITING

Related Publications (1)

  • King A, Omoniyi T, Zasadzinski L, Gaspard C, Gorman D, Saunders M. Interactive Computer-Adaptive Chronic Kidney Disease (I-C-CKD) Education for Hospitalized African American Patients: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Apr 17;14:e66846. doi: 10.2196/66846.

MeSH Terms

Conditions

Renal Insufficiency, ChronicHypertension

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsVascular DiseasesCardiovascular Diseases

Study Officials

  • Milda Saunders, MD

    Associate Professor of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Milda Saunders, MD

CONTACT

Akilah King, MSW

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2023

First Posted

April 15, 2024

Study Start

May 31, 2023

Primary Completion

June 1, 2025

Study Completion (Estimated)

September 1, 2026

Last Updated

January 8, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

Can share individual participant data (IPD) based on researcher data plan and IRB approval

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data will be available 12 months after study completion and will remain available for 24 months
Access Criteria
Require researcher data plan and institutional review board (IRB) approval

Locations